Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07475338
What this trial is testing

Effect of Storytelling on Questionnaire Completion and Quality of Collected Data in an E-Cohort

Who this might be right for
General Population (no Specific Condition or Disease)
SKEZI 500
Not applicableEnded earlyNCT01073436
What this trial is testing

Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha

Who this might be right for
Chronic Myeloid Leukemia
University of Michigan Rogel Cancer Center 7
Large-scale testing (Phase 3)Ended earlyNCT00519090
What this trial is testing

Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia
Novartis Pharmaceuticals 6
Not applicableNot Yet RecruitingNCT07521124
What this trial is testing

ABC Maintenance Therapy for AML

Who this might be right for
Acute Myeloid Leukemia (AML) in Remission
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 104
Large-scale testing (Phase 3)Temporarily pausedNCT05503108
What this trial is testing

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

Who this might be right for
Fasting Mimicking DietHER2-negative Breast CancerHormone Receptor-positive Breast Cancer+3 more
Leiden University Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT02229682
What this trial is testing

Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy

Who this might be right for
Lymphoma,Non-Hodgkin Lymphoma,Extranodal NK/T-cell Lymphoma,Nasal-type,
Sun Yat-sen University 40
Not applicableStudy completedNCT04464590
What this trial is testing

Interest of a Systematic One-year Monitoring by 18F-FDG PET-CT

Who this might be right for
Malignant LymphomaRelapsed Non Hodgkin LymphomaRelapsed Hodgkin's Disease, Adult+1 more
University Hospital, Brest 100
Large-scale testing (Phase 3)Study completedNCT01015196
What this trial is testing

Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Nantes University Hospital 832
Not applicableNot Yet RecruitingNCT07673211
What this trial is testing

Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer

Who this might be right for
Cervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer
Zhejiang Cancer Hospital 60
Not applicableNot Yet RecruitingNCT07206511
What this trial is testing

Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study

Who this might be right for
Unresectable Hepatocellular Carcinom
Shanghai Zhongshan Hospital 278
Large-scale testing (Phase 3)Ended earlyNCT01510184
What this trial is testing

Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy

Who this might be right for
Diffuse Large B-cell LymphomaFollicle Center Lymphoma
Spectrum Pharmaceuticals, Inc 79
Not applicableNot Yet RecruitingNCT07516626
What this trial is testing

Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer

Who this might be right for
Breast CancerLocally Advanced Breast Cancer (LABC)
Atlas University 40
Testing effectiveness (Phase 2)Study completedNCT00858806
What this trial is testing

Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 78
Testing effectiveness (Phase 2)UnknownNCT02955628
What this trial is testing

RICE-ibrutinib in Relapsed DLBCL

Who this might be right for
Diffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Recurrent
Singapore General Hospital 34
Large-scale testing (Phase 3)Study completedNCT01216644
What this trial is testing

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Krankenhaus Nordwest 716
Testing effectiveness (Phase 2)UnknownNCT02511847
What this trial is testing

Trial of Afatinib With Paclitaxel for Neoadjuvant Therapy of TNBC and Research of Biomarkers of Afatinib

Who this might be right for
Triple Negative Breast Cancer
National Taiwan University Hospital 40
Testing effectiveness (Phase 2)UnknownNCT01520558
What this trial is testing

CNDO-109-AANK for AML in First Complete Remission (CR1)

Who this might be right for
Acute Myeloid Leukemia
Coronado Biosciences, Inc. 12
Post-approval studies (Phase 4)Study completedNCT04330040
What this trial is testing

Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer

Who this might be right for
Ovarian CancerBreast Cancer
AstraZeneca 202
Not applicableUnknownNCT04917263
What this trial is testing

IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment.

Who this might be right for
Rectal Cancer
University of Padova 544
Not applicableLooking for participantsNCT07430579
What this trial is testing

Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma

Who this might be right for
Pathological Complete RemissionObjective Response RateImmune-related Adverse Events+1 more
The Second Hospital of Shandong University 25
Next Page